Natus Medical (BABY) Tops Q4 EPS by 1c; Updates FY15 Outlook

Go back to Natus Medical (BABY) Tops Q4 EPS by 1c; Updates FY15 Outlook

Natus Medical Announces Record Fourth Quarter and Full Year 2014 Financial Results

January 28, 2015 7:00 AM EST

-  Increases 2015 revenue and earnings guidance

-  Achieves 2014 non-GAAP operating margin goal of 16%

PLEASANTON, Calif., Jan. 28, 2015 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (Nasdaq: BABY) today announced financial results for the three months and full year ended December 31, 2014.

For the fourth quarter ended December 31, 2014, the Company reported revenue of $94.0 million, an increase of 4% compared to $90.6 million reported for the fourth quarter 2013. GAAP net income was $9.9 million, or $0.30 per diluted share, compared with GAAP net income of $9.4 million, or... More

Natus Medical Announces Entry Into Neurodiagnostic Services Market

January 26, 2015 7:00 AM EST

    Acquires Global Neuro-Diagnostics ("GND"), a Pioneer in Neurodiagnostic Services

PLEASANTON, Calif., Jan. 26, 2015 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (Nasdaq: BABY) today announced that it has entered the neurodiagnostic services market through the acquisition of Global Neuro-Diagnostics ("GND").  GND was profitable in 2014 with revenue of approximately $7 million.

GND's service offers patients a more convenient way to complete routine video EEG testing which can be performed at the home, hospital or physician's office. The service also provides comprehensive reporting and support to the physician.

"GND brings video neurodiagnostics to our growing service... More